Prospective Evaluation of Femoral Tripod Eversion Technique

NCT03357185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2019-07-29

No results posted yet for this study

Summary

Endarteriectomy is considered as the first line treatment of femoral bifurcation atheromatous lesions. Eversion technique, similar to that used for carotid bifurcation, is safe and possible for the majority of the femoral tripod lesions. The major advantage of the eversion technique is the absence of prosthetic material to be performed. However, its use has been scarcely evaluated in the literature to date. This work aims at evaluating the long term safety and the efficacy of eversion femoral technique. Surgical technique was thoroughly described and participants were followed up for two years by serial clinical and doppler US examination.

Conditions

  • Atheromatous

Interventions

PROCEDURE

Femoral eversion

The purpose of this database is to compile the data of patients followed at the René Dubos Hospital Center with symptomatic lower extremity arterial disease (AOMI) (Rutherford 2 to 5) who were operated on by the femoral tripod eversion technique. The database will include data on the operation, possible complications, clinical course of patients and medical and surgical follow-up.

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Jean-Michel DAVAINE · Hôpital NOVO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2016-04-30
Completion
2017-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357185 on ClinicalTrials.gov